Shenzhen - Delayed Quote CNY

Maccura Biotechnology Co.Ltd (300463.SZ)

12.73 +0.16 (+1.27%)
At close: April 26 at 3:04 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Wu Mingjian GM & Director -- -- 1977
Ms. Shan Yin CFO & Director -- -- 1981
Ms. Ping Yu Administrative Director & Manager of Human Resource Department -- -- 1981
Mr. Shengguo Xu Director of Marketing & Director -- -- 1979
Ms. Wei Shi Secretary & Director of Strategic Investment -- -- 1975
Ms. Hui Yang Director of Production - Reagents -- -- 1968

Maccura Biotechnology Co.Ltd

Hi-tech Zone
No. 8, Anhe 2nd Road
Chengdu, 611730
China
86 28 8173 1888 https://www.maccura.com
Sector: 
Healthcare

Description

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers. It provides SARS-COV-2(COVID-19) products that includes nucleic acid detection kit and other products; glucometers; POCT products, such as fluorescence immunoassay analyzers, as well as colloidal gold kits; molecular diagnosis products, such as PCR kit; and pathology products. Maccura Biotechnology Co.Ltd was incorporated in 1994 and is based in Chengdu, China.

Corporate Governance

Maccura Biotechnology Co.Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • May 29, 2023
    Ex-Dividend Date

Upcoming Events